The deal is designed to spur drug development for neurodegenerative conditions like Alzheimer's, Parkinson's and Huntington's diseases.

“The department estimates we need 50 dispensaries in New Jersey to meet demand. We have eight now, and they need 50. It’s not a competitive issue. It’s an access issue,” CCF Chair of the Board Dave Knowlton said.

According to Allergy & Asthma Network President and CEO Tonya Winders, 25 million Americans are living with asthma.

Matawan-based CentralReach is addressing the applied behavior analysis space with products that provide precision teaching, clinical data collection, scheduling, billing, learning management, digital evidence-based programming and more.

Gov. Phil Murphy announced on Saturday that he has a tumor on his left kidney and will undergo a partial nephrectomy. “The prognosis is very good and I’m profoundly grateful to my doctors for detecting the tumor early,” Murphy wrote on Twitter. First Lady Tammy Murphy tweeted: “I know Phil and he’s a fighter. We’re ...

"We're interested in expanding the provision of medical cannabis to the people of this community," said CCF Board Chair Dave Knowlton. "We're also interested in adding to the excitement of revamping Atlantic City, and being a part of the economic growth of the city, and providing employment and economic opportunity."

The company is quitting its PharMEDium compounding business, citing regulatory and commercial challenges, among other factors.

The seven-floor, 243,500-square-foot project is scheduled to open in summer 2021.

The measure is designed to secure Bayonne Medical Center as a full-service institution.

The Rochelle Park-based firm has brought on a government, cyber and security expert, and new hires for three additional, fast-growing sectors.

The hospital is tackling infection prevention, and costs, with an innovative laundering additive, designed to provide post-wash protection against the seven leading pathogens.

In the U.S., more than 23,000 women will be diagnosed, with over 14,000 deaths, this year due to the disease, according to the director of gynecologic oncology at the Patricia Lynch Cancer Center.